Canadian Journal of Public Health

, Volume 91, Supplement 1, pp S4–S9 | Cite as

Dernières données médicales sur l’hépatite C

  • Fondation canadienne du foie
  • Programme d’éducation nationale sur l’hépatite C

Hepatitis C: Medical Information Update

Supplementary material

41997_2000_BF03405099_MOESM1_ESM.pdf (108 kb)
Supplementary material, approximately 111 KB.


  1. 1.
    Organisation mondiale de la santé. Feuille d’information no 164 sur l’hépatite C. Genève, juin 1997.Google Scholar
  2. 2.
    Recommendations for the prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Morbidity and Mortality Weekly Report 1998;47:1–33. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.Google Scholar
  3. 3.
    McQuillan GM, Alter MJ, Moyer LA, et coll. A population-based serologic study of hepatitis C virus infection in the United States. In: Rizzetto M, Purcell RH, Gerin JL, Verme G (Eds.), Viral Hepatitis and Liver Disease, Turin: Edizioni Minerva Medica, 1997; 267–70.Google Scholar
  4. 4.
    Alter MJ, Hadler SC, Judson FN, et coll. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990;264:2231–35.CrossRefGoogle Scholar
  5. 5.
    An integrated protocol to manage health care workers exposed to blood borne pathogens. Can Commun Dis Rep 1997;23S2.Google Scholar
  6. 6.
    Prevention and Control of Hepatitis C: Guidelines and Recommendations. Can Commun Dis Rep 1995;21S2.Google Scholar
  7. 7.
    Stary A, Kopp W, Hoffman H, et coll. Seroepidemiologic study of hepatitis C virus in sexually transmitted disease risk groups. Sex Transm Dis 1992;19:252–58.CrossRefGoogle Scholar
  8. 8.
    Bodsworth NJ, Cunningham P, Kaldor J, Donovan B. Hepatitis C virus infection in a large cohort of homosexually active men: Independent associations with HIV-1 infection and injecting drug use but not sexual behaviour. Genitourin Med 1996;72:118–22.PubMedPubMedCentralGoogle Scholar
  9. 9.
    Alter MJ, Coleman PJ, Alexander WJ, et coll. Importance of heterosexual activity in the trans mission of hepatitis B and non-A, non-B hepati tis. JAMA 1989;262:1201–5.CrossRefGoogle Scholar
  10. 10.
    Thomas DL, Cannon RO, Shapiro CN, et coll. Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases. J Infect Dis 1994;169:990–95.CrossRefGoogle Scholar
  11. 11.
    Polish LB, Tong MJ, Co RL, et coll. Risk factors for hepatitis C virus infection among health care personnel in a community hospital. Am J Infect Control 1993;21:196–200.CrossRefGoogle Scholar
  12. 12.
    Sherman M. CASL Hepatitis Consensus Group. Management of viral hepatitis: Clinical and public health perspectives — a consensus statement. Can J Gastroenterol 1997;11:407–16.CrossRefGoogle Scholar
  13. 13.
    Fattovich G, Giustina G, Degos F, et coll. Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients. Gastro 1997;112:463–72.CrossRefGoogle Scholar
  14. 14.
    Koff RS, Dienstag JL. Extrahepatic manifestations of hepatitis C and the association with alcoholic liver disease. Semin Liver Dis 1995;15:101–9.CrossRefGoogle Scholar
  15. 15.
    NIH Consensus Conference on Management of Hepatitis C. Hepatology 1997;26:2S–10S.CrossRefGoogle Scholar

Copyright information

© The Canadian Public Health Association 2000

Authors and Affiliations

  • Fondation canadienne du foie
    • 1
  • Programme d’éducation nationale sur l’hépatite C
  1. 1.TorontoCanada

Personalised recommendations